Akebia Therapeutics (AKBA) Change in Inventory (2019 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Change in Inventory of $2.5 million for Q1 2026, down 48.72% year-over-year from $5.0 million in Q1 2025, and down 85.42% quarter-over-quarter from $17.4 million in Q4 2025.
Akebia Therapeutics (AKBA) Change in Inventory (2019 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Change in Inventory for 8 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 48.72% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $20.7 million (down 28.38% YoY), while the FY2025 annual figure was $23.1 million, down 18.58% from the prior year.
- Change in Inventory retreated to $2.5 million in Q1 2026 per AKBA's latest filing, from $17.4 million in the prior quarter.
- Across five years, Change in Inventory topped out at $17.4 million in Q4 2025 and bottomed at -$24.5 million in Q4 2022.
- Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.5 million in 2026.
- Annual changes were most pronounced in 2024 — Change in Inventory jumped 528.78% — and 2025, when it sank 1365.87%.
- Akebia Therapeutics' Change in Inventory stood at -$24.5 million in 2022, then jumped by 148.18% to $11.8 million in 2023, then slipped by 27.88% to $8.5 million in 2024, then surged by 105.01% to $17.4 million in 2025, then slumped by 85.42% to $2.5 million in 2026.
- Business Quant data shows AKBA's Change in Inventory at $2.5 million in Q1 2026, $17.4 million in Q4 2025, and -$6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 655,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 655,000.00 |
| Jun 30, 2026 | 655,000.00 |
| Mar 31, 2026 | 2.54 Mn |
| Mar 31, 2026 | 2.54 Mn |
| Dec 31, 2025 | 17.42 Mn |
| Dec 31, 2025 | 17.42 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 8.50 Mn |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | 545,000.00 |
| Sep 30, 2024 | 545,000.00 |
| Jun 30, 2024 | 14.93 Mn |
| Jun 30, 2024 | 14.93 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.43 Mn |